Cart
sales@molnova.com
2,4-dihydroxy-3,4,6-trimethoxychalcone
CAS No. 1776-29-0
2,4-dihydroxy-3,4,6-trimethoxychalcone( ——— )
Catalog No. M39289 CAS No. 1776-29-0
2,4-dihydroxy-3,4,6-trimethoxychalcone
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 854 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2,4-dihydroxy-3,4,6-trimethoxychalcone
-
NoteResearch use only, not for human use.
-
Brief Description2,4-dihydroxy-3,4,6-trimethoxychalcone
-
Description2,4-dihydroxy-3,4,6-trimethoxychalcone
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1776-29-0
-
Formula Weight330.3
-
Molecular FormulaC18H18O6
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CRANAD-28
CRANAD-28 can mark plaques and cerebral amyloid angiopathy.
-
3-O-β-D-Xylopyranosy...
3-O-β-D-Xylopyranosyl-(1→3)-α-L-Rhamnopyranosyl-(1→4)-α-L-arabinopyranosyl hederagenin-28-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl ester
-
Talacotuzumab
Talacotuzumab (JNJ 56022473) is an IgG1 fully humanized CD123 neutralizing monoclonal antibody containing a modified Fc structure.
